Researchers in China suggest that there could be a herbal remedy for H1N1 virus after they compared popular prescription medicine, Tamiflu to a common herbal remedy known as maxingshigan-yinqiaosan.
Researchers at Beijing’s Chao-Yang Hospital compared the effectiveness of maxingshigan-yinqiaosan with Oseltamivir, which is sold under the brand name Tamiflu. Over 410 people, between 15 to 59 years of age, infected with H1N1 virus took part in the study.The researchers divided the participants into four groups, the first group was given a 75mg dose of oseltamivir twice a day, the second group underwent the maxingshigan-yinqiaosan therapy, and the third group was given both oseltamivir and the herbal remedy while the fourth group acted as a control group without any intervention.
All three combinations resulted in significant reductions in the estimated median time to fever resolution as compared to the control group. The time to fever resolution was reduced by 19% with oseltamivir plus maxingshigan–yinqiaosan compared with oseltamivir alone. The study concluded that based on these findings, maxingshigan–yinqiaosan may be used as an alternative treatment of H1N1 influenza virus infection.
The study details appear in the latest issue of the Annals of Internal Medicine.
Source-Medindia
Researchers at Beijing’s Chao-Yang Hospital compared the effectiveness of maxingshigan-yinqiaosan with Oseltamivir, which is sold under the brand name Tamiflu. Over 410 people, between 15 to 59 years of age, infected with H1N1 virus took part in the study.The researchers divided the participants into four groups, the first group was given a 75mg dose of oseltamivir twice a day, the second group underwent the maxingshigan-yinqiaosan therapy, and the third group was given both oseltamivir and the herbal remedy while the fourth group acted as a control group without any intervention.
All three combinations resulted in significant reductions in the estimated median time to fever resolution as compared to the control group. The time to fever resolution was reduced by 19% with oseltamivir plus maxingshigan–yinqiaosan compared with oseltamivir alone. The study concluded that based on these findings, maxingshigan–yinqiaosan may be used as an alternative treatment of H1N1 influenza virus infection.
The study details appear in the latest issue of the Annals of Internal Medicine.
Source-Medindia
No comments:
Post a Comment